The size of metastatic foci and lymph nodes yielding false-negative and false-positive lymph node staging with positron emission tomography in patients with lung cancer

被引:78
作者
Nomori, H
Watanabe, K
Ohtsuka, T
Naruke, T
Suemasu, K
Uno, K
机构
[1] Saiseikai Cent Hosp, Dept Thorac Surg, Minato Ku, Tokyo 1080073, Japan
[2] Nishidai Clin, Tokyo, Japan
关键词
D O I
10.1016/j.jtcvs.2003.08.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: We examined the sizes of lymph nodes and metastatic foci within the lymph nodes that affect false-positive and false-negative C, lymph node staging by positron emission tomography in lung cancer. Methods: Preoperative positron emission tomography and computed tomography scans were performed for 564 lymph node stations in 80 patients with peripheral-type lung cancer. The sizes of both the lymph nodes and the metastatic foci within the lymph nodes were measured, and these measurements were compared with those obtained with positron emission tomography scanning. To establish general sizes of metastatic foci within the lymph nodes, 277 metastatic lymph nodes in operative specimens previously resected from another 111 patients with lung cancer were examined as a control. Results: The sensitivity was significantly higher for positron emission tomography than for computed tomographic scanning (P = .026). The sizes of metastatic foci within lymph nodes that showed false-negative (n = 8) and true-positive (n = 28) with positron emission tomography ranged from 0.5 to 9 mm (3 +/- 1 mm) and from 4 to 18 mm (10 +/- 3 mm), respectively (P < .001). None of the metastatic foci smaller than 4 mm could be detected with positron emission tomography scanning. The review of the 277 previously resected metastatic lymph nodes showed that 89 (32%) had metastatic foci smaller than 4 mm. The sizes of true-positive (n = 28) and false-positive (n = 10) lymph nodes ranged from 6 to 15 mm (10 +/- 2 mm) and from 9 to 16 mm (12 +/- 2 mm), respectively (P < .01). None of the false-positive lymph nodes was smaller than 9 mm. Conclusions: Although positron emission tomography was superior to computed tomography scanning in lymph node staging in lung cancer, positron emission tomography was unable to distinguish metastatic foci smaller than 4 mm, which were not unusual sizes for lymph node metastases in lung cancer. Positive lymph nodes with positron emission tomography smaller than 9 mm are likely to be true-positive rather than false-positive.
引用
收藏
页码:1087 / 1092
页数:6
相关论文
共 20 条
[1]   Staging of the mediastinum: Value of positron emission tomography imaging in non-small cell lung cancer [J].
Bury, T ;
Paulus, P ;
Dowlati, A ;
Corhay, JL ;
Weber, T ;
Ghaye, B ;
Schoffers, J ;
Limet, R ;
Albert, A ;
Rigo, P ;
Radermecker, M .
EUROPEAN RESPIRATORY JOURNAL, 1996, 9 (12) :2560-2564
[2]   MEDIASTINAL STAGING OF NON-SMALL-CELL LUNG-CANCER WITH POSITRON EMISSION TOMOGRAPHY [J].
CHIN, R ;
WARD, R ;
KEYES, JW ;
CHOPLIN, RH ;
REED, JC ;
WALLENHAUPT, S ;
HUDSPETH, AS ;
HAPONIK, EF .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1995, 152 (06) :2090-2096
[3]   DIAGNOSTIC EFFICACY OF PET-FDG IMAGING IN SOLITARY PULMONARY NODULES - POTENTIAL ROLE IN EVALUATION AND MANAGEMENT [J].
DEWAN, NA ;
GUPTA, NC ;
REDEPENNING, LS ;
PHALEN, JJ ;
FRICK, MP .
CHEST, 1993, 104 (04) :997-1002
[4]   Metastases from non-small cell lung cancer: Mediastinal staging in the 1990s - Meta-analytic comparison of PET and CT [J].
Dwamena, BA ;
Sonnad, SS ;
Angobaldo, JO ;
Wahl, RL .
RADIOLOGY, 1999, 213 (02) :530-536
[5]   Mediastinal lymph node staging in suspected lung cancer:: comparison of positron emission tomography with F-18-fluorodeoxyglucose and mediastinoscopy [J].
Graeter, TP ;
Hellwig, D ;
Hoffmann, K ;
Ukena, D ;
Kirsch, CM ;
Schäfers, HJ .
ANNALS OF THORACIC SURGERY, 2003, 75 (01) :231-235
[6]   Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluation of small (&lt;1 cm), intermediate (1 to 3 cm), and large (&gt;3 cm) lymph node lesions [J].
Gupta, NC ;
Graeber, GM ;
Bishop, HA .
CHEST, 2000, 117 (03) :773-778
[7]  
Gupta NC, 1996, J NUCL MED, V37, P943
[8]   Mediastinal lymph node sampling following positron emission tomography with fluorodeoxyglucose imaging in lung cancer staging [J].
Gupta, NC ;
Tamim, WJ ;
Graeber, GG ;
Bishop, HA ;
Hobbs, GR .
CHEST, 2001, 120 (02) :521-527
[9]   Validation of FDG positron emission tomography for differentiation of unknown pulmonary lesions [J].
Imdahl, A ;
Jenkner, S ;
Brink, I ;
Nitzsche, E ;
Stoelben, E ;
Moser, E ;
Hasse, J .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2001, 20 (02) :324-329
[10]  
KUBOTA R, 1992, J NUCL MED, V33, P1972